Pulmonary hypertension in bronchopulmonary dysplasia

被引:26
作者
Mourani, Peter M. [1 ,2 ,3 ]
Mullen, Mary [4 ,5 ]
Abman, Steven H. [1 ,2 ,3 ]
机构
[1] Univ Colorado Denver, Pediat Heart Lung Ctr, Sch Med, Dept Pediat,Sect Crit Care Med, Aurora, CO USA
[2] Childrens Hosp, Aurora, CO USA
[3] Univ Colorado Denver, Pediat Heart Lung Ctr, Sch Med, Dept Pediat,Sect Pulm Med, Aurora, CO USA
[4] Harvard Univ, Sch Med, Dept Cardiol, Boston, MA 02115 USA
[5] Childrens Hosp Boston, Boston, MA USA
关键词
Bronchopulmonary dysplasia; Prematurity; Pulmonary hypertension; Inhaled nitric oxide; Angiogenesis; Sildenafil; Endothelin; Endothelin-receptor antagonists; Prostacyclin;
D O I
10.1016/j.ppedcard.2009.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bronchopulmonary dysplasia (BPD), the chronic lung disease that follows oxygen and ventilator therapy of premature neonates, is characterized by significant cardiac and pulmonary sequelae. Since its original description in the late '60s, poor outcome in BPD has been strongly associated with late pulmonary hypertension (PH). Despite progressive improvements in the care of preterm infants, PH still remains a significant cause of late morbidity and mortality in premature infants. More recently, experimental and clinical studies have shown that lung vascular growth is abnormal in infants with BPD, which may contribute to abnormalities of lung airspace structure, alters gas exchange with respiratory infections and exercise, and further increases the risk for developing PH. Current data are limited with regards to many fundamental aspects of pulmonary vascular disease and PH in infants with BPD, including: basic mechanisms that alter lung vascular growth and development after premature birth and may contribute to the pathogenesis of PH; the prevalence and natural history of PH in infants with BPD; approaches to screen and diagnose PH in this group; and effective therapies for the prevention and treatment of PH in infants with BPD. This article discusses recent observations and recommendations in the clinical approach to PH in BPD and highlights current gaps in our knowledge. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 50 条
[41]   An update on the diagnosis and management of bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension [J].
Berkelhamer, Sara K. ;
Mestan, Karen K. ;
Steinhorn, Robin .
SEMINARS IN PERINATOLOGY, 2018, 42 (07) :432-443
[42]   Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future [J].
Fike, Candice D. ;
Aschner, Judy L. .
PHARMACEUTICALS, 2023, 16 (04)
[43]   Characteristics and sex differences in bronchopulmonary dysplasia-related pulmonary hypertension [J].
Zhou, Dansha ;
Wang, Ting ;
Chen, Yuqin ;
Zheng, Yulin ;
Zhou, Yingzhen ;
Zhang, Mingxiang ;
Liu, Aofeng ;
Hu, Biao ;
Fu, Shuang ;
Wu, Ruixian ;
Chen, Wei ;
Jiang, Xiaoli ;
Ye, Zehui ;
Shi, Yuan ;
Fu, Zhou ;
Wang, Jian .
BMC PULMONARY MEDICINE, 2025, 25 (01)
[44]   Pulmonary Hypertension Specific Treatment in Infants With Bronchopulmonary Dysplasia [J].
Kadmon, Gili ;
Schiller, Ofer ;
Dagan, Tamir ;
Bruckheimer, Elchanan ;
Birk, Einat ;
Schonfeld, Tommy .
PEDIATRIC PULMONOLOGY, 2017, 52 (01) :77-83
[45]   Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia [J].
Krishnan, Usha ;
Feinstein, Jeffrey A. ;
Adatia, Ian ;
Austin, Eric D. ;
Mullen, Mary P. ;
Hopper, Rachel K. ;
Hanna, Brian ;
Romer, Lew ;
Keller, Roberta L. ;
Fineman, Jeffrey ;
Steinhorn, Robin ;
Kinsella, John P. ;
Ivy, D. Dunbar ;
Rosenzweig, Erika Berman ;
Raj, Usha ;
Humpl, Tilman ;
Abman, Steven H. .
JOURNAL OF PEDIATRICS, 2017, 188 :24-+
[46]   B-type natriuretic peptide is a biomarker for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia [J].
Cuna, Alain ;
Kandasamy, Jegen ;
Fineberg, Naomi ;
Sims, Brian .
RESEARCH AND REPORTS IN NEONATOLOGY, 2013, 3 :33-36
[47]   Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants [J].
Arjaans, Sanne ;
Wagner, Brandie D. ;
Mourani, Peter M. ;
Mandell, Erica W. ;
Poindexter, Brenda B. ;
Berger, Rolf M. F. ;
Abman, Steven H. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 318 (04) :L644-L654
[48]   Children with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Treated with Pulmonary Vasodilators-The Pediatric Cardiologist Point of View [J].
Migdal, Anna ;
Sadel-Wieczorek, Anna ;
Ryciak, Edyta ;
Mirecka-Rola, Alicja ;
Brzezinska-Rajszys, Grazyna ;
Zuk, Malgorzata .
CHILDREN-BASEL, 2021, 8 (05)
[49]   Accuracy of Brain Natriuretic Peptide for Diagnosing Pulmonary Hypertension in Severe Bronchopulmonary Dysplasia [J].
Avitabile, Catherine M. ;
Ansems, Sophie ;
Wang, Yan ;
Fraga, Maria V. ;
Kirpalani, Haresh M. ;
Zhang, Huayan ;
Mercer-Rosa, Laura ;
Jensen, Erik A. .
NEONATOLOGY, 2019, 116 (02) :147-153
[50]   Somatic growth and the risks of bronchopulmonary dysplasia and pulmonary hypertension: connecting epidemiology and physiology [J].
Underwood, Mark A. ;
Wedgwood, Stephen ;
Lakshminrusimha, Satyan ;
Steinhorn, Robin H. .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 97 (03) :197-205